Filing Details
- Accession Number:
- 0001822629-23-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-15 20:39:03
- Reporting Period:
- 2023-08-11
- Accepted Time:
- 2023-08-15 20:39:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1822629 | Nikhil Lalwani | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-08-11 | 56,666 | $57.75 | 353,390 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-08-15 | 11,616 | $29.00 | 365,006 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-08-15 | 11,616 | $61.13 | 353,390 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2023-08-15 | 11,616 | $29.00 | 11,616 | $29.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
168,027 | 2030-09-08 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $60.68 to $61.87, inclusive.
- 25% of the total options vested on each of September 8, 2021 and September 8, 2022. 25% of the total options will vest on each of September 8, 2023 and September 8, 2024.